In animal and cell models, CECs and CD45+ CECs suppress T-cell activation and inhibit the production of pro-inflammatory cytokines which contribute to cancer development and human immuno-deficiency virus (HIV) infection (8, 9, 12). The gene discussed is PTPRC; the disease is cancer.